MONOGRAPH CAPITAL
Monograph Capital is a life sciences venture firm. We find and fund groundbreaking life sciences companies to transform promising science into real, life-changing treatments for people across the world.
MONOGRAPH CAPITAL
Status:
Active
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-06-29 | MiroBio | Monograph Capital investment in Series B - MiroBio | 80 M GBP |
2021-12-02 | AviadoBio | Monograph Capital investment in Series A - AviadoBio | 58.6 M GBP |
More informations about "Monograph Capital"
Team โ Monograph Capital
The Monograph Capital team is comprised of M.D.s and PhDs with decades of experience in finance, biomedical research and clinical medicine, operating across North America and โฆSee details»
Monograph Capital - Crunchbase Investor Profile & Investments
Monograph Capital is a life sciences venture firm. We find and fund groundbreaking life sciences companies to transform promising science into real, life-changing treatments for people across โฆSee details»
Monograph Capital - LinkedIn
We fund groundbreaking life sciences companies to transform promising science into life-changing treatments. Monograph was founded to invest in life sciences companies that seek to create new or...See details»
Monograph Capital - Investments, Portfolio & Company Exits
Monograph Capital is a life sciences venture firm.See details»
Monograph Capital - EU-Startups
Monograph Capital is a venture firm focused on life sciences. With a dedicated emphasis on the life sciences sector, Monograph Capital invests in innovative companies and technologies that โฆSee details»
Monograph Capital investment portfolio | PitchBook
Founded in 2021, Monograph Capital is a venture capital investment firm based in London, United Kingdom. The firm seeks to invest in life sciences companies that seek to create new or โฆSee details»
Monograph Capital - LinkedIn
Monograph Capital | 882 followers on LinkedIn. We fund groundbreaking life sciences companies to transform promising science into life-changing treatments. | Monograph was founded to โฆSee details»
Monograph Capital | SuperVenture - Informa Connect
Monograph is a life sciences venture firm founded by a team of seasoned biotech investors and company builders. Led by our chair Fred Cohen (Managing Partner at TPG Biotech and Vida โฆSee details»
Monograph Capital | Institution Profile - Private Equity International
Monograph Capital is an investment firm based in London, United Kingdom with offices in San Francisco and Dallas-Fort Worth. It invests in life sciences companies that seek to create new โฆSee details»
Portfolio โ Monograph Capital
Monograph co-led the Series A financing round in August 2021. Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences for Up to $1.8B.See details»
Monograph Capital on LinkedIn: Monograph is on a mission to โฆ
Monograph is on a mission to connect the best biotech executives - case in point with Maxion bringing Arndt Schottelius, MD PhD as their CEO. ? Weโre very excited to announce our new โฆSee details»
Monograph Capital - VC Firm Profile - Gaebler.com Venture โฆ
We find and fund groundbreaking life sciences companies to transform promising science into real, life-changing treatments across the world. Our team comprises M.D.s and PhDs with โฆSee details»
Fundopedia | Monograph Capital
Monograph Capital finds and funds groundbreaking life sciences companies to transform promising science into real, life-changing treatments across the world.See details»
Member profile: Monograph Capital | BIA - bioindustry.org
Monograph Capital is a life sciences venture firm based in London and San Francisco focused on bridging resources to scale companies that change the practice of medicine.See details»
Monograph Capital - Contacts, Employees, Board Members
Monograph Capital has 4 current employee profiles, including Partner Tim Funnell. Monograph Capital is a life sciences venture firm.See details»
Monograph Capital I: Fund Performance - PitchBook
Aug 10, 2023ย ยท Monograph Capital I is a 2021 vintage venture capital fund managed by Monograph Capital. The fund is located in London, United Kingdom and will invest in the โฆSee details»
Get in Touch โ Monograph Capital
[email protected] Follow Monograph on LinkedIn. ยฉ 2024 Monograph Capital - All Rights ReservedSee details»
Tim Funnell - Partner @ Monograph Capital - Crunchbase
Tim Funnell has 5 current jobs including Director & Interim CEO at Ascend Gene & Cell Therapies, Investor Director at AviadoBio, and Partner at Monograph Capital. Additionally, Tim โฆSee details»
News - Monograph Capital
[email protected] Follow Monograph on LinkedIn. ยฉ 2024 Monograph Capital - All Rights ReservedSee details»